Results 21 to 30 of about 154,837 (273)

Evaluation of Melatonin Secretion and Metabolism Exponents in Patients with Ulcerative and Lymphocytic Colitis [PDF]

open access: yesMolecules, 2018
Inflammatory bowel diseases, particularly ulcerative colitis (UC) and lymphocytic colitis (LC), affect many people. The role of melatonin in the pathogenesis of UC is precisely determined, whereas in LC it remains unknown.
Cezary Chojnacki   +4 more
doaj   +2 more sources

Microscopic Colitis and Reproductive Factors Related to Exposure to Estrogens and Progesterone [PDF]

open access: yesDrug Target Insights, 2013
Microscopic colitis (MC) often debuts around or after menopause and is divided into lymphocytic- and collagenous colitis. The aim of this study was to examine whether factors influencing sex hormone levels differed between subgroups of MC as well as ...
Bodil Roth, Jonas Manjer, Bodil Ohlsson
doaj   +2 more sources

Failure of Added Dietary Gluten to Induce Small Intestinal Histopathological Changes in Patients with Watery Diarrhea and Lymphocytic Colitis

open access: yesCanadian Journal of Gastroenterology, 1996
Lymphocytic colitis is a form of microscopic colitis usually characterized by watery diarrhea and often associated with biopsy-defined celiac disease. Two patients with lymphocytic colitis and normal small intestinal biopsies who were administered 40 g ...
Hugh James Freeman
doaj   +2 more sources

Latent Lymphocytic Enterocolitis Associated with Celiac Disease Manifesting after Resection for Colon Cancer: Case Report and Review of the Literature [PDF]

open access: yesCanadian Journal of Gastroenterology, 2008
Lymphocytic colitis, a cause of chronic watery diarrhea, is histologically characterized by increased intraepithelial lymphocytosis. Studies have associated this disorder with celiac disease, although there are no reports of patients with both ...
Vikram Tangri   +2 more
doaj   +2 more sources

Use of budesonide in the treatment of microscopic colitis

open access: yesThe Saudi Journal of Gastroenterology, 2010
Collagenous colitis and lymphocytic colitis, the two types of microscopic colitis, cause watery diarrhea. Budesonide, a glucocorticoid medication with limited systemic availability, is commonly used to treat these illnesses.
Tangri Vikram, Chande Nilesh
doaj   +2 more sources

Familial Microscopic Colitis

open access: yesCanadian Journal of Gastroenterology, 2001
Collagenous and lymphocytic colitis are two inflammatory conditions of the colon that are often collectively referred to as microscopic colitis. The present report describes what is believed to be the third published case of familial microscopic colitis.
Ayman Assad Abdo   +2 more
doaj   +2 more sources

Evaluation of Endoscopist and Pathologist Factors Affecting the Incidence of Microscopic Colitis [PDF]

open access: yesCanadian Journal of Gastroenterology, 2012
BACKGROUND: Microscopic colitis (MC) is an umbrella term for collagenous colitis (CC) and lymphocytic colitis (LC). The incidence of these diseases is increasing for unclear reasons.
Christopher N Andrews   +4 more
doaj   +2 more sources

Familial Occurrence of Lymphocytic Colitis

open access: yesCanadian Journal of Gastroenterology, 2001
The familial occurrence of lymphocytic colitis in a female parent and her two female children is reported. No other genetically based disorder, including celiac disease, was evident.
Hugh J Freeman
doaj   +3 more sources

Lymphocytic Colitis With Enterocolic Lymphocytic Phlebitis. [PDF]

open access: yesACG Case Rep J
ABSTRACT Enterocolic lymphocytic phlebitis is a rare lymphocytic vasculitis afflicting the gastrointestinal veins without involving the arterial system. Lymphocytic colitis is a more common pathology described as lymphocytic inflammation of the colonic epithelium. Concurrence of both these pathologies is extremely rare.
Nadeem A   +9 more
europepmc   +3 more sources

Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis. [PDF]

open access: yesCureus, 2021
Checkpoint inhibitors (CPIs) are a new class of drugs that have changed the treatment and prognosis of several malignancies, even in their advanced stages. These drugs have increased patient survival rates.
Khan J, Katona T.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy